Soligenix
SNGX
#10889
Rank
A$11 M
Marketcap
A$0.51
Share price
-3.90%
Change (1 day)
-89.36%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -A$17.47 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$16.54 Million a decrease over its 2024 earnings that were of -A$13.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$17.47 Million5.59%
2025 -A$16.54 Million26.72%
2024 -A$13.06 Million22.96%
2023 -A$10.62 Million-45.74%
2022 -A$19.56 Million11.88%
2021 -A$17.49 Million-32.37%
2020 -A$25.85 Million83.18%
2019 -A$14.12 Million11.57%
2018 -A$12.65 Million19.29%
2017 -A$10.61 Million33%
2016 -A$7.98 Million-19.7%
2015 -A$9.93 Million5.16%
2014 -A$9.44 Million
2010 -A$10.66 Million26.12%
2009 -A$8.45 Million75.1%
2008 -A$4.83 Million-45.38%
2007 -A$8.84 Million-22.84%
2006 -A$11.45 Million66.15%
2005 -A$6.89 Million-16.65%
2004 -A$8.27 Million13.28%
2003 -A$7.3 Million-11.88%
2002 -A$8.29 Million-59.44%
2001 -A$20.42 Million378.18%
2000 -A$4.27 Million-38.53%
1999 -A$6.95 Million-18.43%
1998 -A$8.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.26 B-222,070.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.78 B-90,591.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.69 B-65,535.84%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$25.35 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$58.31 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.17 B-19,503.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.85 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$82.5 M-604.96%๐Ÿ‡บ๐Ÿ‡ธ USA